Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials.
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Reduced saturated fat (SFA) consumption is recommended to reduce coronary heart disease (CHD), but there is an absence of strong supporting evidence from randomized controlled trials (RCTs) of clinical CHD events and few guidelines focus on any specific replacement nutrient. Additionally, some public health groups recommend lowering or limiting polyunsaturated fat (PUFA) consumption, a major potential replacement for SFA. METHODS AND FINDINGS: We systematically investigated and quantified the effects of increased PUFA consumption, as a replacement for SFA, on CHD endpoints in RCTs. RCTs were identified by systematic searches of multiple online databases through June 2009, grey literature sources, hand-searching related articles and citations, and direct contacts with experts to identify potentially unpublished trials. Studies were included if they randomized participants to increased PUFA for at least 1 year without major concomitant interventions, had an appropriate control group, and reported incidence of CHD (myocardial infarction and/or cardiac death). Inclusions/exclusions were adjudicated and data were extracted independently and in duplicate by two investigators and included population characteristics, control and intervention diets, follow-up duration, types of events, risk ratios, and SEs. Pooled effects were calculated using inverse-variance-weighted random effects meta-analysis. From 346 identified abstracts, eight trials met inclusion criteria, totaling 13,614 participants with 1,042 CHD events. Average weighted PUFA consumption was 14.9% energy (range 8.0%-20.7%) in intervention groups versus 5.0% energy (range 4.0%-6.4%) in controls. The overall pooled risk reduction was 19% (RR = 0.81, 95% confidence interval [CI] 0.70-0.95, p = 0.008), corresponding to 10% reduced CHD risk (RR = 0.90, 95% CI = 0.83-0.97) for each 5% energy of increased PUFA, without evidence for statistical heterogeneity (Q-statistic p = 0.13; I(2) = 37%). Meta-regression identified study duration as an independent determinant of risk reduction (p = 0.017), with studies of longer duration showing greater benefits. CONCLUSIONS: These findings provide evidence that consuming PUFA in place of SFA reduces CHD events in RCTs. This suggests that rather than trying to lower PUFA consumption, a shift toward greater population PUFA consumption in place of SFA would significantly reduce rates of CHD. Please see later in the article for the Editors' Summary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Effects on CHD risk of consuming PUFA, carbohydrate, or MUFA in place of SFA. Predicted effects are based on changes in the TC∶HDL-C ratio in short-term trials (e.g., each 5%E of PUFA replacing SFA lowers TC∶HDL-C ratio by 0.16) [11] coupled with observed associations between the TC∶HDL-C ratio and CHD outcomes in middle-aged adults (each 1 unit lower TC∶HDL-C is associated with 44% lower risk of CHD) [15]. Evidence for effects of dietary changes on actual CHD events comes from the present meta-analysis of eight RCTs for PUFA replacing SFA and from the Women's Health Initiative RCT for carbohydrate replacing SFA (n = 48,835, ∼3%E reduction in SFA over 8 years) [39]. Evidence for observed relationships of usual dietary habits with CHD events comes from a pooled analysis of 11 prospective cohort studies [38].](https://figures.cochat.ai/paper-figures/0f2eb91663234c2bbacf7d8c07e93e67/effects-on-coronary-heart-disease-of-increasing-polyunsaturated-fat-in-place-of-figure-3.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In the presidential advisory of the AHA by Sacks et al. (27), the literature search strategy was not described, similarly to the study by Mozaffarian et al. (26)”
From Saturated Fat Restriction for Cardiovascular Disease Prevention: A Systematic Review and Meta-analysis of Randomized Controlled Trials (2025) · cites this paper as [26]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In order to get an overall estimate of the impact of dietary modifications on the CV risk, different meta-analyses have been performed, sometimes with inconsistent outcomes. 135,136”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [136]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For instance, total saturated fat, carbohydrate, and protein each appear relatively neutral for CHD; while effects of total monounsaturated fat remain uncertain (see below).21, 349”
From Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review (2016) · cites this paper as [349]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“LA is also associated with significantly lower risk of CHD (Figure 7), whether in comparison to carbohydrate or saturated fat;350 and in meta-analysis of controlled clinical trials, consumption of n-6 rich vegetable oils, in place of animal fats, reduces CHD events (Figure 7).349”
From Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review (2016) · cites this paper as [349]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notably, in these trials, the average intake of n-6 polyunsaturated fat was ~15% energy,349 higher than current guidelines that recommend up to 10-11% energy from polyunsaturated fat.370”
From Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review (2016) · cites this paper as [349]
Experimental — accuracy not yet measured
18 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722 · cited 1×
“Potential for publication bias was assessed by visually inspecting a funnel plot of the treatment effect versus SE [30] and statistically using the Begg adjusted-rank correlation test [31].”
MethodMeta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 3×
“Statistical Analysis The overall pooled effect was calculated using random effects meta-analysis, which accounts for heterogeneity in treatment effects among studies, using the methods of Dersimonian and Laird [28] with inverse-variance (SE) weighting.”
MethodOperating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Trumbo, P., Schlicker, S., Yates, A. A., & Poos, M. (2002) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(02)90346-9 · Cited by 5,993
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826
Moher, D., Pham, B., Jones, A., Cook, D. J., Jadad, A. R., Moher, M., Tugwell, P., & Klassen, T. P. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01085-x · Cited by 3,560 · cited 2×
“We assessed study quality using the validated Jadad scale [27], which includes criteria relating to randomization, blinding, and withdrawals and dropouts that are together summed to generate an overall quality score between 0 and 5.”
BackgroundMethodSwinburn, B., Baba, N. H., Belhadj, M., Deurenberg‐Yap, M., Djazayery, A., Forrester, T., Galuska, D. A., Herman, S. T., James, W. P. T., Kabangu, J. R. M., et al. (2003) · World Health Organization eBooks · Cited by 3,453
Simopoulos, A. P. (2008) · Experimental Biology and Medicine · doi:10.3181/0711-mr-311 · Cited by 2,915 · cited 1×
“However, surprisingly, some scientists and organizations argue that consumption of n-6 PUFA, by far the predominant dietary PUFA, will actually increase CHD risk and have recommended reduced consumption [21–23], and the Institute of Medicine recommends only a relatively modest range of 5%–10% energy (%E) consumption f…”
BackgroundDanaei, G., Ding, E. L., Mozaffarian, D., Taylor, B., Rehm, J., Murray, C. J. L., & Ezzati, M. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000058 · Cited by 2,860 · cited 1×
“need to be revisited, particularly as PUFA appears to be the primary evidence-based replacement for SFA. Finally, whereas on a population-level even a small shift from SFA to PUFA consumption would produce meaningful reductions in CHD risk, the relatively modest magnitude of plausible benefit (∼10% lower risk for 5%E…”
BackgroundSelf-citationMensink, R. P., Zock, P. L., Kester, A. D., & Katan, M. B. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.5.1146 · Cited by 2,811 · cited 5×
“16; this can be compared to no significant change in the TC:HDL-C ratio when SFA is replaced by carbohydrate [11].”
BackgroundInfluentialBurr, M. L., Gilbert, J. F., Holliday, R. M., Elwood, P. C., Fehily, A. M., Rogers, S., Sweetnam, P. M., & Deadman, N. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90828-3 · Cited by 2,610
Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60527-3 · Cited by 2,516
(2007) · The Lancet · doi:10.1016/s0140-6736(07)61778-4 · Cited by 2,331 · cited 4×
“61) [15], the ranges of ages included in the present trials.”
BackgroundInfluential(1999) · PubMed · Cited by 2,062
Diet, Nutrition, and the Prevention of Chronic Diseases
Leong, A. S.-Y. (1992) · Pathology · doi:10.1016/s0031-3025(16)36541-2 · Cited by 1,628
GISSI-HF investigators (2008) · The Lancet · doi:10.1016/s0140-6736(08)61239-8 · Cited by 1,350
Marchioli, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, R., Franzosi, M. G., Geraci, E., Levantesi, G., Maggioni, A. P., et al. (2002) · Circulation · doi:10.1161/01.cir.0000014682.14181.f2 · Cited by 1,311
Moher, D., Jadad, A. R., Nichol, G., Penman, M., Tugwell, P., & Walsh, S. (1995) · Controlled Clinical Trials · doi:10.1016/0197-2456(94)00031-w · Cited by 1,308
Siri-Tarino, P. W., Sun, Q., Hu, F. B., & Krauss, R. M. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27725 · Cited by 1,253 · cited 1×
“However, effects of such a strategy on clinical CHD events are surprisingly poorly established in both randomized controlled trials (RCTs) [1–8] and prospective cohort studies [9].”
BackgroundHoward, B. V., Van Horn, L., Hsia, J., Manson, J. E., Stefanick, M. L., Wassertheil-Smoller, S., Kuller, L. H., LaCroix, A. Z., Langer, R. D., Lasser, N. L., et al. (2006) · JAMA · doi:10.1001/jama.295.6.655 · Cited by 1,091
Dietary Guidelines for Americans 2005
SKOLNIK, N. S., & KING, M. (2005) · Family Practice News · doi:10.1016/s0300-7073(05)71075-6 · Cited by 1,070
Jakobsen, M. U., O’Reilly, E. J., Heitmann, B. L., Pereira, M. A., Bälter, K., Fraser, G. E., Goldbourt, U., Hallmans, G., Knekt, P., Liu, S., et al. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.27124 · Cited by 1,026 · cited 4×
“The most robust evidence to date comes from a recent report of pooled individual-level data from 11 cohort studies in America, Europe, and Israel, including 344,696 adults and 5,249 CHD events [38].”
BackgroundResultInfluentialWatts, G. F., Lewis, B., Lewis, E. S., Coltart, D. J., Smith, L. D. R., Swan, A. V., Brunt, J. N. H., & Mann, J. I. (1992) · The Lancet · doi:10.1016/0140-6736(92)90863-x · Cited by 843 · cited 1×
“[8] was clearly a potential outlier both in terms of sample size and risk reduction.”
BackgroundDietary fat intake and risk of type 2 diabetes in women
Salmerón, J., Hu, F. B., Manson, J. E., Stampfer, M. J., Colditz, G. A., Rimm, E. B., & Willett, W. C. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.6.1019 · Cited by 818 · cited 2×
“PUFA consumption may also improve insulin resistance [16,17] and reduce systemic inflammation [18–20].”
BackgroundResultRelationship of plasma polyunsaturated fatty acids to circulating inflammatory markers.
Ferrucci, L., Cherubini, A., Bandinelli, S., Bartali, B., Corsi, A., Lauretani, F., Martin, A., Andres-Lacueva, C., Senin, U., & Guralnik, J. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1303 · Cited by 696 · cited 2×
“PUFA consumption may also improve insulin resistance [16,17] and reduce systemic inflammation [18–20].”
BackgroundResultDAYTON, S., PEARCE, M. L., HASHIMOTO, S., DIXON, W. J., & TOMIYASU, U. (1969) · Circulation · doi:10.1161/01.cir.40.1s2.ii-1 · Cited by 595
Pischon, T., Hankinson, S. E., Hotamisligil, G. S., Rifai, N., Willett, W. C., & Rimm, E. B. (2003) · Circulation · doi:10.1161/01.cir.0000079224.46084.c2 · Cited by 560 · cited 2×
“PUFA consumption may also improve insulin resistance [16,17] and reduce systemic inflammation [18–20].”
BackgroundResultOh, K. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi085 · Cited by 499 · cited 1×
“Results should also not be extrapolated to effects of increasing PUFA as replacement for carbohydrate, although based on changes in TC:HDL-C in feeding studies [11], and observed relationships with clinical events in cohort studies [38,42], one would predict CHD benefit from such replacement.”
BackgroundEFFECT OF CHOLESTEROL-LOWERING DIET ON MORTALITY FROM CORONARY HEART-DISEASE AND OTHER CAUSES
Miettinen, M., Karvonen, M., Turpeinen, O., Elosuo, R., & Paavilainen, E. (1972) · The Lancet · doi:10.1016/s0140-6736(72)92208-8 · Cited by 497
Fatty acid modulation of endothelial activation
De Caterina, R., Liao, J. K., & Libby, P. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.1.213s · Cited by 486
CONTROLLED TRIAL OF SOYA-BEAN OIL IN MYOCARDIAL INFARCTION
(1968) · The Lancet · doi:10.1016/s0140-6736(68)90746-0 · Cited by 476
The Oslo Diet-Heart Study: Eleven-Year Report
LEREN, P. (1970) · Circulation · doi:10.1161/01.cir.42.5.935 · Cited by 458
Assessing the Quality of Randomized Controlled Trials:Current Issues and Future Directions
Moher, D., Jadad, A. R., & Tugwell, P. (1996) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300009570 · Cited by 436 · cited 1×
“been proposed for judging quality of randomized trials in metaanalyses, although the validity and utility of different quality scores has been debated [26].”
BackgroundSummers, L. K. M., Fielding, B. A., Bradshaw, H. A., Ilic, V., Beysen, C., Clark, M. L., Moore, N. R., & Frayn, K. N. (2002) · Diabetologia · doi:10.1007/s00125-001-0768-3 · Cited by 414 · cited 2×
“PUFA consumption may also improve insulin resistance [16,17] and reduce systemic inflammation [18–20].”
BackgroundResultMozaffarian, D., & Clarke, R. (2009) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602976 · Cited by 410 · cited 1×
“For example, daily consumption of 20 g soybean oil or 30 g canola oil, as an isocaloric replacement for other macronutrients, would increase PUFA consumption by ,5%E on a 2000 kcal/d diet [43].”
MethodSelf-citationDietary fat intake and prevention of cardiovascular disease: systematic review
Hooper, L., Summerbell, C. D., Higgins, J. P. T., Thompson, R. L., Capps, N. E., Smith, G. D., Riemersma, R. A., & Ebrahim, S. (2001) · BMJ · doi:10.1136/bmj.322.7289.757 · Cited by 389 · cited 1×
“Prior meta-analyses of RCTs have either studied the effects of very heterogeneous dietary fat interventions on very heterogeneous combinations of cardiovascular outcomes [10], or studied effects of dietary fat interventions on intermediate risk markers, such as blood lipids [11].”
BackgroundDietary Prevention of Coronary Heart Disease: The Finnish Mental Hospital Study
TURPEINEN, O., J, M., PEKKARINEN, M., MIETTINEN, M., ELOSUO, R., & PAAVILAINEN, E. (1979) · International Journal of Epidemiology · doi:10.1093/ije/8.2.99 · Cited by 384 · cited 5×
“H o sp it al (m e n ) [4 ] , 4 6 1 m id d le -a g e d”
BackgroundInfluentialEvaluation of old and new tests of heterogeneity in epidemiologic meta-analysis
Takkouche, B., Cadarso-Suarez, C., & Spiegelman, D. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009981 · Cited by 380 · cited 1×
“Heterogeneity between studies was evaluated using the Dersimonian and Laird Q-statistic, the I(2) statistic, and meta-regression [28,29].”
MethodEmployer's liability for cancer of the scrotum
(1968) · The Lancet · doi:10.1016/s0140-6736(68)92497-5 · Cited by 308
Test of effect of lipid lowering by diet on cardiovascular risk. The Minnesota Coronary Survey.
Frantz, I. D., Dawson, E. A., Ashman, P. L., Gatewood, L. C., Bartsch, G. E., Kuba, K., & Brewer, E. R. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.1.129 · Cited by 293
Corn Oil in Treatment of Ischaemic Heart Disease
Rose, G. A., Thomson, W. B., & Williams, R. T. (1965) · BMJ · doi:10.1136/bmj.1.5449.1531 · Cited by 197 · cited 1×
“The identified RCTs included a total of 1,042 CHD events among 13,614 participants (Table 1) [1–8,32–34].”
BackgroundControlled Trial of Soya-Bean Oil in Myocardial Infarction
Allhoff, P., Laaser, U., & Heinrich, J. (1991) · Kompendium der Lipid-Studien · doi:10.1007/978-3-642-95642-3_15 · Cited by 178
CONTROLLED TRIAL OF A DIET HIGH IN UNSATURATED FAT FOR PREVENTION OF ATHEROSCLEROTIC COMPLICATIONS
Dayton, S., Pearce, M., Goldman, H., Harnish, A., Plotkin, D., Shickman, M., Winfield, M., Zager, A., & Dixon, W. (1968) · The Lancet · doi:10.1016/s0140-6736(68)91531-6 · Cited by 166 · cited 1×
“Reduction in saturated fatty acid (SFA) consumption is traditionally a major focus of dietary recommendations to reduce coronary heart disease (CHD) risk. However, effects of such a strategy on clinical CHD events are surprisingly poorly established in both randomized controlled trials (RCTs)”
Background(2005) · PubMed · Cited by 146
Self-citationDietary Prevention of Coronary Heart Disease in Women: The Finnish Mental Hospital Study
MIETTINEN, M., TURPEINEN, O., KARVONEN, M., PEKKARINEN, M., PAAVILAINEN, E., & ELOSUO, R. (1983) · International Journal of Epidemiology · doi:10.1093/ije/12.1.17 · Cited by 127 · cited 5×
“The identified RCTs included a total of 1,042 CHD events among 13,614 participants (Table 1) [1–8,32–34].”
BackgroundInfluentialZatonski, W., Campos, H., & Willett, W. (2008) · European Journal of Epidemiology · doi:10.1007/s10654-007-9195-1 · Cited by 119 · cited 2×
“Recent ecological studies across nations over time also support this contention, with changes in population CHD mortality being most strongly related to increased consumption of vegetable oils that contained PUFA, particularly the n-3 PUFA alpha-linolenic acid, rather than decreases in animal fats or increases in over…”
BackgroundResultThe Japan Society for Lipid Nutrition Recommends to Reduce the Intake of Linoleic Acid
Hamazaki, T., & Okuyama, H. (2003) · KARGER eBooks · doi:10.1159/000073796 · Cited by 76
Weaver, C., Nicklas, T., & Britten, P. (2005) · Nutrition Today · doi:10.1097/00017285-200505000-00003 · Cited by 47
Research works printed but not linked: 1
- S Dayton, 1969, Diet high in unsaturated fat. A controlled clinical trial., Minn Med, 52, 1237
Cited by
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Self-citationLim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Metadata
- Authors
- Mozaffarian, D., Micha, R., & Wallace, S.
- Affiliations
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Corresponding author
- Mozaffarian, Dariush
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-03-23
- Volume
- 7
- Issue
- 3
- Pages
- e1000252
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC2843598
- OpenAlex
- W2097226936
- Cited by
- 1,215
- References
- 49
- Citations by year
- 2026: 32 · 2025: 52 · 2024: 59 · 2023: 63 · 2022: 69 · 2021: 80 · 2020: 81 · 2019: 76 · 2018: 76 · 2017: 74 · 2016: 98 · 2015: 105 · 2014: 85 · 2013: 89 · 2012: 77
- FWCI
- 9.42
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Bill and Melinda Gates Foundation
- Chicago Community Trust
- GlaxoSmithKline
- World Health Organization
- National Institutes of Health
- U.S. Food and Drug Administration
- National Heart, Lung, and Blood Institute (R01HL085710)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- polyunsaturated fatty acids, saturated fat replacement, coronary artery disease, myocardial infarction, cardiovascular mortality, dietary fat, cardiovascular risk reduction, study duration, meta-regression, dietary intervention trials, omega-3 fatty acids, omega-6 fatty acids, dietary guidelines, publication bias
- MeSH terms
- Coronary Disease, Dietary Fats, Fatty Acids, Fatty Acids, Unsaturated, Feeding Behavior, Humans, Meta-Analysis as Topic, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.